Home
Live Updates
Gastroenterology Month in Review: January 2024 : comparemela.com
Gastroenterology Month in Review: January 2024
Our January 2024 Month in Review spotlights the FDA approval of a new indication of dupilumab (Dupixent) for pediatric eosinophilic esophagitis, new clinical trial data, and research about the prevention and management of IBD.
Related Keywords
Evan Dellon ,
Dupilumab Dupixent ,
Julie Khlevner ,
Drug Administration ,
University Of North Carolina Chapel Hill ,
Contemporary Pediatric ,
Esophageal Diseases ,
North Carolina Chapel Hill ,
Pediatric Gastrointestinal Motility Center ,
Columbia University Medical Center ,
Ibd ,
Inflammatory Bowel Disease ,
Constipation ,
Linaclotide ,
Eosinophilic Esophagitis ,
Dupilumab ,
Bustekinumab ,
Ulcerative Colitis ,
comparemela.com © 2020. All Rights Reserved.